Jennison Associates’s CareDx CDNA Stock Holding History

Jennison Associates’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-41,110	Closed	-$1.48M	–	647
2019 Q2	$1.48M	Sell	41,110 -3,554	-8%	-$114K	﹤0.01%	516
2019 Q1	$1.41M	Hold	44,664	–	–	﹤0.01%	515
2018 Q4	$1.12M	Buy	+44,664	New	+$1.15M	﹤0.01%	536

Other funds holding CDNA

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Jennison Associates's CDNA Position: Q3 2019 in Review

Jennison Associates sold out of CareDx (CDNA) in Q3 2019, closing a stake of 41,110 shares — an estimated $1.48M sold.

Jennison Associates first reported a position in CDNA in Q4 2018 and held it in 3 quarters. The position peaked at $1.48M in Q2 2019. 174 funds tracked by Wall St. Rank hold CDNA as of Q3 2019.

Jennison Associates reported no remaining CareDx position as of Q3 2019 after selling out during the quarter.
Jennison Associates sold 41,110 CareDx shares in Q3 2019, an estimated $1.48M.
Jennison Associates first reported a position in CareDx in Q4 2018 and held it in 3 quarters.
Jennison Associates's CareDx position peaked at $1.48M in Q2 2019.
174 funds tracked by Wall St. Rank held CareDx as of Q3 2019.

Based on Jennison Associates's 13F filing for Q3 2019, filed 8 Nov 2019.